Skip to content

Evaluation of Microbial Status in Gastritis Patients in Different Periodontal Conditions

Evaluation Of Periodontal Status In Gastritis Patients With Clinical And Microbiological Parameters

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07378540
Enrollment
30
Registered
2026-01-30
Start date
2023-11-01
Completion date
2024-04-01
Last updated
2026-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastritis, Periodontal Diseases

Keywords

gastritis, microbiome, metagenomic analysis, dysbiosis

Brief summary

The aim of this study to evaluate the microbial profile in gastritis and healthy patients in different periodontal conditions via next generation technologies.

Detailed description

This study aims to determine the density of bacteria associated with periodontal disease and to evaluate oral dysbiosis in gastritis patients using metagenomic analysis.

Interventions

OTHERsaliva collection

collecting unstimulated saliva

Sponsors

Aydin Adnan Menderes University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* no systemic diseases other than gastritis non-smoker

Exclusion criteria

* Participants who took regular medications that could affect of periodontal tissue or oral microbiome pregnancy or lactation Patients who received periodontal treatment within the last 6 months

Design outcomes

Primary

MeasureTime frameDescription
Salivary microbial profile1 monthTo compare the oral flora profiles of the study groups, a microbiome-based next-generation sequencing approach targeting the 16S rRNA gene was employed. In this metagenomic study, following DNA extraction, phylogenetic classification was performed using the V3-V4 hypervariable regions of the 16S rRNA gene. Using the obtained data, total bacterial diversity and density were compared through alpha and beta diversity analyses. Bacterial taxa that differed between the groups were identified using LEfSe analysis.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 24, 2026